Brandi L. Roberts
2021 - Longboard Pharmaceuticals
In 2021, Brandi L. Roberts earned a total compensation of $1.3M as Chief Financial Officer at Longboard Pharmaceuticals.
Compensation breakdown
Bonus | $30,000 |
---|---|
Non-Equity Incentive Plan | $153,509 |
Option Awards | $765,266 |
Salary | $373,269 |
Other | $11,792 |
Total | $1,333,836 |
Roberts received $765.3K in option awards, accounting for 57% of the total pay in 2021.
Roberts also received $30K in bonus, $153.5K in non-equity incentive plan, $373.3K in salary and $11.8K in other compensation.
Rankings
In 2021, Brandi L. Roberts' compensation ranked 7,725th out of 12,415 executives tracked by ExecPay. In other words, Roberts earned more than 37.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,725 | 38th |
Manufacturing | 3,407 | 38th |
Chemicals And Allied Products | 1,511 | 36th |
Drugs | 1,345 | 36th |
Pharmaceutical Preparations | 992 | 36th |
Roberts' colleagues
We found two more compensation records of executives who worked with Brandi L. Roberts at Longboard Pharmaceuticals in 2021.
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020